MindWalk Holdings (HYFT) Operating Expenses (2020 - 2026)
MindWalk Holdings (HYFT) reported Operating Expenses of $4.4 million for Q1 2026, down 76.41% year-over-year from $18.8 million in Q1 2025, and up 112744.7% quarter-over-quarter from $3919.4 in Q4 2025.
MindWalk Holdings (HYFT) Operating Expenses (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Operating Expenses data on file, last reported at $4.4 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $4.4 million, down 76.41% year-over-year; the trailing twelve-month figure through Jan 2026 was $4.4 million (down 99.9% YoY), and the FY2025 annual result was $33818.2, down 99.89% from the prior year.
- Operating Expenses rose to $4.4 million in Q1 2026 per HYFT's latest filing, from $3919.4 in the prior quarter.
- Over five years, Operating Expenses peaked at $5.1 billion in Q3 2023 and troughed at $3919.4 in Q4 2025.
- A 5-year average of $559.9 million and a median of $5.6 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses jumped 138078.72% in 2022, then tumbled 100.0% in 2025.
- A 5-year view of Operating Expenses shows it stood at $8.0 million in 2022, then plunged by 44.78% to $4.4 million in 2023, then declined by 9.91% to $4.0 million in 2024, then tumbled by 99.9% to $3919.4 in 2025, then jumped by 112744.7% to $4.4 million in 2026.
- Business Quant data shows HYFT's Operating Expenses at $4.4 million in Q1 2026, $3919.4 in Q4 2025, and $4282.3 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -67.40 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 4.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 4.42 Mn |
| Oct 31, 2025 | 3,919.42 |
| Jul 31, 2025 | 4,282.29 |
| Apr 30, 2025 | 15,474.79 |
| Jan 31, 2025 | 18.75 Mn |
| Oct 31, 2024 | 3.97 Mn |
| Jul 31, 2024 | 4.30 Bn |
| Apr 30, 2024 | 16.24 Mn |
| Jan 31, 2024 | 4.84 Mn |
| Oct 31, 2023 | 4.41 Mn |
| Jul 31, 2023 | 5.13 Bn |
| Apr 30, 2023 | 6.96 Mn |
| Jan 31, 2023 | 5.59 Mn |
| Oct 31, 2022 | 7.98 Mn |
| Jul 31, 2022 | 9.76 Mn |
| Apr 30, 2022 | 6.00 Mn |
| Jan 31, 2022 | 5.45 Mn |
| Oct 31, 2021 | 5,777.26 |
| Jul 31, 2021 | 4.86 Mn |
| Apr 30, 2021 | 4.67 Mn |